Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR2 | P21452 | 8/20 | 0.79 |
| ▸ | TACR3 | P29371 | 6/20 | 0.42 |
| ▸ | TACR1 | P25103 | 6/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CCR5 | P51681 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7749162 | 0.98 | TACR2 (0.77) | TACR2TACR3TACR1CYP3A4CYP2D6 | |
| SCHEMBL6976267 | 0.92 | TACR2 (0.84) | TACR2TACR3TACR1CYP3A4CYP2D6 | |
| SCHEMBL4631279 | 0.91 | TACR2 (0.85) | TACR2TACR3TACR1CYP3A4CYP2D6 | |
| SCHEMBL4631147 | 0.91 | TACR2 (0.81) | TACR2TACR3TACR1CYP3A4CYP2D6 | |
| Hydrochloric Acid SCHEMBL7749204 | 0.90 | TACR2 (0.83) | TACR2TACR3TACR1CYP3A4CYP2D6 | |
| Hydrochloric Acid SCHEMBL7749084 | 0.89 | TACR2 (0.79) | TACR2TACR3TACR1CYP3A4CYP2D6 | |
| SCHEMBL4630144 | 0.89 | TACR2 (0.82) | TACR2TACR3TACR1CYP3A4CYP2D6 | |
| SCHEMBL4630899 | 0.89 | TACR2 (0.82) | TACR2TACR3TACR1CYP3A4CYP2D6 | |
| SCHEMBL4631297 | 0.89 | TACR2 (0.65) | TACR2TACR3TACR1CYP3A4CYP2D6 | |
| SCHEMBL3091194 | 0.88 | TACR2 (1.00) | TACR2TACR3TACR1CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1923391-A1 | Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them. | sanofi-aventis (FR) | 2008-05-21 | — | — | EP | disclosed |
| EP-1688416-A1 | Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them | Sanofi-Aventis (FR) | 2006-08-09 | — | — | EP | disclosed |
| EP-1340754-A1 | Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them | SANOFI-SYNTHELABO (FR) | 2003-09-03 | — | — | EP | disclosed |
| EP-0807111-B1 | SUBSTITUTED HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | SANOFI SYNTHELABO (FR) | 2002-08-14 | — | — | EP | disclosed |
| EP-1156049-A1 | Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them | SANOFI-SYNTHELABO (FR) | 2001-11-21 | — | — | EP | disclosed |
| WO-1996023787-A1 | SUBSTITUTED HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | SANOFI (FR) | 1996-08-08 | — | — | WO | disclosed |